Molnumize 200mg Capsule 10s

Introduction to Molnumize 200mg Capsule 10s

Molnumize 200mg Capsule 10s is an oral medication primarily used to treat mild to moderate COVID-19 in adults at risk of severe illness. By reducing the severity of symptoms, it helps lower the risk of hospitalization.

Composition of Molnumize 200mg Capsule 10s

Molnumize 200mg Capsule 10s contains Molnupiravir as its active ingredient. Molnupiravir works by interfering with the virus's ability to replicate, introducing errors into its genetic material to prevent effective multiplication.

Uses of Molnumize 200mg Capsule 10s

• Treatment of mild to moderate COVID-19 in adults
• Reduces severity of COVID-19 symptoms
• Lowers risk of COVID-19 related hospitalization

Side effects of Molnumize 200mg Capsule 10s

• Mild diarrhea
• Nausea
• Dizziness

Precautions of Molnumize 200mg Capsule 10s

Molnumize 200mg Capsule 10s is not recommended during pregnancy due to potential risks to the unborn baby. It is also not advised for individuals under 18 years old. Always inform your doctor of any allergies or medical conditions before starting this medication.

How to Take Molnumize 200mg Capsule 10s

The usual dose of Molnumize 200mg Capsule 10s for adults is 800 mg taken twice daily, orally, for five days. Always follow your doctor's specific dosing instructions for the correct usage.

Conclusion of Molnumize 200mg Capsule 10s

Molnumize 200mg Capsule 10s, containing Molnupiravir, is a therapeutic class medication used to treat mild to moderate COVID-19. It is manufactured to help reduce symptoms and hospitalization risks. Always consult your healthcare provider for personalized advice and follow their instructions carefully.